Tested blood or tissue patterns in head and neck cancer
Treatments studied
Part of Cancer clinical trials.
This study looks at specific genetic “methylation” patterns in people with head and neck squamous cell carcinoma. The results may help doctors understand the disease better and identify who may benefit from future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must sign a consent form agreeing to take part
- If you’re in the cancer group: you must have confirmed head and neck squamous cell carcinoma
- If you’re in the comparison group: you must have a normal ENT (ear, nose, throat) exam
- You cannot have another active cancer
- Your other health problems must be controlled (not “uncontrolled”)
- You must be able to understand the study and provide informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with head and neck cancer that has not spread to distant parts of the body. It is a non-treatment study that will look at the molecular features of your tumor from a biopsy sample to help guide future treatment decisions.
This study collects blood and tumor tissue samples to analyze biological markers in patients with advanced head and neck squamous cell carcinoma before starting immunotherapy. The goal is to better understand how these markers relate to treatment response.
This study looks at “circulating tumor DNA” (tumor DNA found in blood) in people with newly diagnosed, locally advanced head and neck squamous cell cancer. Researchers want to see how the blood DNA levels relate to the cancer and how it may guide treatment after surgery.
This trial is testing a new blood test (called a liquid biopsy) to better understand and predict the course of head and neck cancers that have come back or spread. If you join, researchers will use a special chip to look at your immune cells and tumor cells in your blood.
This study looks at whether certain blood tests can help predict how head and neck cancer will respond to treatment. If you are planning surgery for squamous cell cancer of the throat, voice box, or mouth, this trial may offer more information about your outlook.
This study looks at “immune signals” in blood, saliva, and stool to learn more about head and neck cancers (especially squamous cell carcinoma). It may help researchers find patterns that improve understanding of disease or how treatment should be guided.
Hear when a new Head and Neck Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.